The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ranibizumab     Quarter: 2016Q3

Total Records: 133     Number of Pages: 7

DRUGNAME PT EventCount
Ranibizumab Sinusitis 4
Ranibizumab Strabismus 4
Ranibizumab Stress 4
Ranibizumab Visual impairment 4
Ranibizumab VIth nerve paralysis 4
RANIBIZUMAB Bile duct stone 3
RANIBIZUMAB Cholelithiasis 3
RANIBIZUMAB Cholestasis 3
Ranibizumab Corneal abrasion 3
Ranibizumab Diabetes mellitus 3
Ranibizumab Drug ineffective 3
Ranibizumab Dry eye 3
Ranibizumab Eye irritation 3
Ranibizumab Eyelid irritation 3
Ranibizumab Gait disturbance 3
RANIBIZUMAB Gastritis 3
RANIBIZUMAB Gastritis erosive 3
Ranibizumab Heterophoria 3
Ranibizumab Intraocular pressure test abnormal 3
RANIBIZUMAB Liver abscess 3

Total Records: 133     Number of Pages: 7